4D Molecular Therapeutics (FDMT) FCF Margin Growth (3y) (2023 - 2026)
4D Molecular Therapeutics (FDMT) FCF Margin Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 10,029.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 723.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | 4D Molecular Therapeutics | 656.48 Mn | 656.48 Mn | - | 724,842.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 724,842.00 |
| Dec 31, 2025 | 186,698.00 |
| Sep 30, 2025 | -4.76 Mn |
| Jun 30, 2025 | -28.00 Mn |
| Mar 31, 2025 | -34.02 Mn |
| Dec 31, 2024 | -432.88 Mn |
| Sep 30, 2024 | -106.71 Mn |
| Jun 30, 2024 | -59.41 Mn |
| Mar 31, 2024 | -10.56 Mn |
| Dec 31, 2023 | 14.07 Mn |
| Sep 30, 2023 | 18,420.00 |
| Jun 30, 2023 | -965,897.00 |
| Mar 31, 2023 | -907,719.00 |